Adjupanrix (previously Pandemic influenza vaccine (H5N1) (split virion, inactivated, adjuvanted) GlaxoSmithKline Biologicals) Եվրոպական Միություն - իսլանդերեն - EMA (European Medicines Agency)

adjupanrix (previously pandemic influenza vaccine (h5n1) (split virion, inactivated, adjuvanted) glaxosmithkline biologicals)

glaxosmithkline biologicals s.a. - hættu inflúensuveiru, óvirkt, innihalda mótefnavaka: a / vietnam / 1194/2004 (h5n1) eins og álag notað (nibrg-14) - influenza, human; immunization; disease outbreaks - bóluefni - fyrirbyggjandi inflúensu í opinberlega lýst faraldur ástandið. bólusetning gegn heimsfaraldri inflúensu ætti að nota í samræmi við opinbera leiðbeiningar.

Livopan Lyfjagas undir þrýstingi 50/50 % Իսլանդիա - իսլանդերեն - LYFJASTOFNUN (Icelandic Medicines Agency)

livopan lyfjagas undir þrýstingi 50/50 %

linde sverige ab - dinitrogenii oxidum; oxygenium - lyfjagas undir þrýstingi - 50/50 %